Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05622721

REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs

Sponsor: University of Pennsylvania

View on ClinicalTrials.gov

Summary

Antimicrobial therapy can lead to disruption of the gut microbiome and infection with Clostridioides difficile, a disease associated with high morbidity and mortality, particularly among the elderly. Drawing on observations that pet ownership and close contact with pets are protective against colonization with C. difficile and recurrence of C. difficile infection, the proposed study will test the hypothesis that microbiota that provide colonization resistance against C. difficile are shared between patients and their pets and that pet contact can mitigate antimicrobial-associated gut dysbiosis and the risk of C. difficile infection. This study will further define epidemiologic and pathophysiologic characteristics of C. difficile infection and gut microbiome dysbiosis that could enhance therapeutic options for these conditions, potentially through non-invasive interventions involving animal contact.

Official title: Impact of Pet Contact on Antimicrobial-associated Dysbiosis and Clostridioides Difficile Infection

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2022-05-30

Completion Date

2026-05-01

Last Updated

2026-03-06

Healthy Volunteers

No

Locations (1)

The Robert Schattner Center, University of Pennsylvania, School of Dental Medicine

Philadelphia, Pennsylvania, United States